Pharma Analytical Conclave 2019

India is the largest provider of generic drugs globally. Indian pharmaceutical sector industry supplies over 50% of global demand for various vaccines, 40% of generic demand in the US and 25 % of all medicine in UK. The pharmaceutical sector was valued at US$ 33 billion in 2017. The country's pharmaceutical industry is expected to expand at a CAGR of 22.4 per cent over 2015-20 to reach US$ 55 billion. India's pharmaceutical exports stood at US$ 17.27 billion in FY18 and have reached US$ US$ 15.52 billion in FY19 (up to January 2019). Medicine spending in India is projected to grow 9-12 % over the next five years, leading India to become one of the top 10 countries in terms of medicine spending.

Going forward, better growth in domestic sales would also depend on the ability of companies to align their product portfolio towards chronic therapies for diseases such as such as cardiovascular, anti-diabetes, anti-depressants and anti-cancers that are on the rise.

In this limelight, CPhI Conferences is pleased to launch the Pharma Analytical Conclave on 08-09 August, 2019 at Novotel Hyderabad Convention Centre. A 2-day comprehensive conclave will commence with a Strategic Conference on innovation, regulatory updates and current challenges in pharma industry, along with parallel sessions on, Impurity Profiling, Aseptic Processing & Sterile Manufacturing. The key objective of this summit is to deliberate on most crucial topics to enlighten the R&D and manufacturing professionals in pharma and bio-pharma industry.

Key Highlights

Market Overview and Future Trends of the Indian Pharmaceuticals Industry
Changing Dynamics of the Global Regulatory Ecosystem in India
Innovations and New Technologies in Research and Development
Optimization and Scalability of Manufacturing Processes
Impurity Profiling-Elemental and Genotoxic Impurities
Aseptic Processing and Single-use Manufacturing Processes


TRACK 1: Overview

Pharma Analytical Conference is a 2-day strategic summit to address the most critical, technical and commercial challenges along with the way forward in the R&D and manufacturing domain.

TRACK 2: Overview

Impurity Profiling workshop will focus on details delineated in the ICH M7 and Q3D guidelines and elaborate on the challenges that industry is experiencing when attending elemental and genotoxic impurities in drug substances and drug products.

TRACK 3: Overview

Aseptic Processing and Sterile Manufacturing workshop will deliberate on technological advancements and key innovations in aseptic processing and sterilization processes.


Event Partners

Silver Partners

Exhibit Partners

Media Partners